These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38346111)

  • 1. MRI-based prostate cancer classification using 3D efficient capsule network.
    Li Y; Wynne J; Wang J; Roper J; Chang CW; Patel AB; Shelton J; Liu T; Mao H; Yang X
    Med Phys; 2024 Jul; 51(7):4748-4758. PubMed ID: 38346111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-trained convolutional neural networks for automated detection of prostate cancer in multi-parametric MRI.
    Yang X; Liu C; Wang Z; Yang J; Min HL; Wang L; Cheng KT
    Med Image Anal; 2017 Dec; 42():212-227. PubMed ID: 28850876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint Prostate Cancer Detection and Gleason Score Prediction in mp-MRI via FocalNet.
    Cao R; Mohammadian Bajgiran A; Afshari Mirak S; Shakeri S; Zhong X; Enzmann D; Raman S; Sung K
    IEEE Trans Med Imaging; 2019 Nov; 38(11):2496-2506. PubMed ID: 30835218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-kernel graph embedding for detection, Gleason grading of prostate cancer via MRI/MRS.
    Tiwari P; Kurhanewicz J; Madabhushi A
    Med Image Anal; 2013 Feb; 17(2):219-35. PubMed ID: 23294985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.
    Alberts AR; Roobol MJ; Verbeek JFM; Schoots IG; Chiu PK; Osses DF; Tijsterman JD; Beerlage HP; Mannaerts CK; Schimmöller L; Albers P; Arsov C
    Eur Urol; 2019 Feb; 75(2):310-318. PubMed ID: 30082150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-aided diagnosis of prostate cancer using a deep convolutional neural network from multiparametric MRI.
    Song Y; Zhang YD; Yan X; Liu H; Zhou M; Hu B; Yang G
    J Magn Reson Imaging; 2018 Dec; 48(6):1570-1577. PubMed ID: 29659067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semi-automatic classification of prostate cancer on multi-parametric MR imaging using a multi-channel 3D convolutional neural network.
    Aldoj N; Lukas S; Dewey M; Penzkofer T
    Eur Radiol; 2020 Feb; 30(2):1243-1253. PubMed ID: 31468158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fully automated detection of prostate transition zone tumors on T2-weighted and apparent diffusion coefficient (ADC) map MR images using U-Net ensemble.
    Wong T; Schieda N; Sathiadoss P; Haroon M; Abreu-Gomez J; Ukwatta E
    Med Phys; 2021 Nov; 48(11):6889-6900. PubMed ID: 34418108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
    Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
    J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated glioma grading on conventional MRI images using deep convolutional neural networks.
    Zhuge Y; Ning H; Mathen P; Cheng JY; Krauze AV; Camphausen K; Miller RW
    Med Phys; 2020 Jul; 47(7):3044-3053. PubMed ID: 32277478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep Learning-Based Interpretable AI for Prostate T2W MRI Quality Evaluation.
    Belue MJ; Law YM; Marko J; Turkbey E; Malayeri A; Yilmaz EC; Lin Y; Johnson L; Merriman KM; Lay NS; Wood BJ; Pinto PA; Choyke PL; Harmon SA; Turkbey B
    Acad Radiol; 2024 Apr; 31(4):1429-1437. PubMed ID: 37858505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A deep dive into understanding tumor foci classification using multiparametric MRI based on convolutional neural network.
    Zong W; Lee JK; Liu C; Carver EN; Feldman AM; Janic B; Elshaikh MA; Pantelic MV; Hearshen D; Chetty IJ; Movsas B; Wen N
    Med Phys; 2020 Sep; 47(9):4077-4086. PubMed ID: 32449176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-based texture analysis of the primary tumor for pre-treatment prediction of bone metastases in prostate cancer.
    Wang Y; Yu B; Zhong F; Guo Q; Li K; Hou Y; Lin N
    Magn Reson Imaging; 2019 Jul; 60():76-84. PubMed ID: 30917943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer lesion detection, volume quantification and high-grade cancer differentiation using cancer risk maps derived from multiparametric MRI with histopathology as the reference standard.
    Gibbons M; Simko JP; Carroll PR; Noworolski SM
    Magn Reson Imaging; 2023 Jun; 99():48-57. PubMed ID: 36641104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of machine learning of apparent diffusion coefficient (ADC) and T2-weighted (T2W) radiomic features in PI-RADS version 2.1 category 3 lesions to predict prostate cancer diagnosis.
    Lim CS; Abreu-Gomez J; Thornhill R; James N; Al Kindi A; Lim AS; Schieda N
    Abdom Radiol (NY); 2021 Dec; 46(12):5647-5658. PubMed ID: 34467426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of apparent diffusion coefficient values and ratios for the prediction of prostate cancer aggressiveness across different MRI acquisition settings.
    Karaarslan E; Altan Kus A; Alis D; Karaarslan UC; Saglican Y; Argun OB; Kural AR
    Diagn Interv Radiol; 2022 Jan; 28(1):12-20. PubMed ID: 35142611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive estimation of prostate cancer aggressiveness using diffusion-weighted MRI and 3D proton MR spectroscopy at 3.0 T.
    Thörmer G; Otto J; Horn LC; Garnov N; Do M; Franz T; Stolzenburg JU; Moche M; Kahn T; Busse H
    Acta Radiol; 2015 Jan; 56(1):121-8. PubMed ID: 24504488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated diagnosis of prostate cancer in multi-parametric MRI based on multimodal convolutional neural networks.
    Le MH; Chen J; Wang L; Wang Z; Liu W; Cheng KT; Yang X
    Phys Med Biol; 2017 Jul; 62(16):6497-6514. PubMed ID: 28582269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.